1 hr ago | BioSpace
Effimune With Its Lead Drug Candidate FR104, Has Been Selected...
Effimune With Its Lead Drug Candidate FR104, Has Been Selected Through the Consortium TRIAD, Under the European Union FP7 Funding Program Nantes, France, 13 February 2012.
11 hrs ago | Medical News
Benefits of long-term Kineret therapy in people with NOMID
A new study shows that Kineret , a medication approved for the treatment of rheumatoid arthritis , is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease .
Injured boomers beware: Know when to see doctor
It happened to nurse Jane Byron years after an in-line skating fall, business owner Haralee Weintraub while doing "men's" push-ups, and avid cyclist Gene Wilberg while lifting a heavy box.
Hospitals running out of cancer drug
Hospitals across the nation could soon run out of a drug used to treat childhood leukemia, The New York Times reports.
Rheumatoid arthritis program scheduled for Thursday at Riverside Dining Center
The Bay County Division on Aging offers "In the Know About Rheumatoid Arthritis" program at 11 a.m. Feb.
NIH Study Shows Benefits of Long-term Kineret Therapy in People with Rare Inflammatory Disease
A new study shows that Kineret , a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease .
Nearly 1 in 20 US adults over 50 have fake knees
Nearly 1 in 20 Americans older than 50 have artificial knees, or more than 4 million people, according to the first national estimate showing how common these replacement joints have become in an aging population.
FDA Sets Shortcut Path for Biosimilar Drugs
The Food and Drug Administration on Thursday created the first shortcut to the U.S. market for "biosimilar" drugs - cheaper versions of expensive and complex medicines made from biological matter.
Seven Diseases Big Pharma Hopes You Get in 2012
Rheumatoid arthritis is a serious and dangerous disease. But so are pharma's immune-suppressing biologic drugs like Remicade, Enbrel, and Humira, which are pushed for treating it.
RA and Preventative Health Screening: Gettinga
Medications for rheumatoid arthritis can be hard on your stomach. Between heartburn, acid reflux, gas, GERD and other gastrointestinal shenanigans, chances are that sooner or later your doctor will suggest you get scoped.
Scottish Business Briefing - Wednesday February 8, 2012
WELCOME to scotsman.com's Scottish Business Briefing. Every morning we bring you a comprehensive round-up of all news affecting business in Scotland today.
Vibex MTX: The Cherry On Top Of The Antares Investment Story
I initiated coverage of Antares on December 8, 2011 with a buy rating. Important factors driving my recommendation were its broad based relationship with Teva for developing injectable pharmaceuticals and the recently approved Anturol, a gel based product for urinary incontinence.
Sistemic to Work with TiGenix On Landmark EUR 5. ...
The project, REGENER-AR, will bring the first stem cell therapy treatment product for rheumatoid arthritis, Cx611, through final research and clinical development.
Benitec Biopharma and Medistem Technologies Successfully Combined in...
SYDNEY, AUSTRALIA and SAN DIEGO, CA -- -- 02/06/12 -- Benitec Biopharma and Medistem announced today the successful treatment of rheumatoid arthritis in preclinical models using Benitec Biopharma's patented gene silencing technology applied to stem cell-derived immune system cells called dendritic cells.
Rigel Pharma Has More Room To Run
So far this has been a great year for biotech, as investors have been more than happy to look past the risks and embrace the opportunities in the pipeline.
Alternative Therapies Offer Arthritis Pain Relief
An estimated 50 million Americans are living with arthritis, and while the pain, stiffness and joint deformities that often go along with it can be debilitating, medical experts say there are treatments that can bring relief to help sufferers live full and productive lives.
To improve delivery of protein drugs, researchers have developed a way to make highly concentrated, injectable suspensions of proteins .
Genmab A/S: Company Profile and SWOT Analysis - new company profile report published
The company uses its cutting-edge technology to create and develop products to address unmet medical needs of oncology, infectious diseases, rheumatoid arthritis and other inflammatory conditions.
The JC Virus Antibody Test Goes Public
Biogen Idec was pleased to announce last week that the FDA has approved an update to the prescription labeling of their monthly IV monoclonal antibody medication for multiple sclerosis known as Tysabri .
Northwestern study finds rheumatoid arthritis patients not exercising enough
Although exercise for patients with rheumatoid arthritis is essential, a new study led by a Northwestern researcher found people with this condition are often completely inactive.
Also on Topix